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Abstract
We have previously identified two Xenopus homologues of mammalian IQGAP, XIQGAP1 and XIQGAP2, which show high homology with
human IQGAP1 and IQGAP2, respectively. In order to clarify function of the IQGAPs during development, we performed knock-down
experiments on the XIQGAPs in Xenopus laevis embryos by microinjecting morpholino antisense oligonucleotides into blastomeres at the two-cell
stage. Suppression of XIQGAP2 expression caused ectodermal lesions in the neurula stage embryos. While suppression of XIQGAP1 expression
alone did not show any obvious defect in subsequent developmental processes, simultaneous knock-down of both XIQGAPs caused the ectodermal
lesions during the gastrula stage. Histological studies suggested that a loss of cell adhesion in the ectodermal and mesodermal layers of the embryos
caused the defect. The suppression of XIQGAP2 expression resulted in loss of actin filaments, β-catenin, and XIQGAP1 from cell borders in the
ectoderm, although it did not affect the expression levels of these proteins. Furthermore, it inhibited Ca2+-induced reaggregation of embryonic cells
which had been dissociated in a Ca2+/Mg2+-free medium. These results strongly suggest that XIQGAP2 is crucial for cell adhesion during early
development in Xenopus.
© 2007 Elsevier Inc. All rights reserved.Keywords: IQGAP; Cell-to-cell adhesion; Xenopus laevis; MorpholinoIntroduction
IQGAPs have originally been identified in mammalian cells
as potential effectors of Rho-family small GTPases, Rac and
Cdc42. In mammals, three IQGAPs, IQGAP1, IQGAP2 and
IQGAP3, have been reported (Brill et al., 1996; Weissbach et
al., 1994; Wang et al., 2007). All the IQGAPs are multi-domain
molecules having a calponin-homology (CH) domain which
binds F-actin, IQGAP-specific repeats, a single WW domain,
four IQ motifs which mediate interactions with calmodulin, andAbbreviations: XIQGAP1-AS, XIQGAP1 antisense oligonucleotide; XIQ-
GAP2-AS, XIQGAP2 antisense oligonucleotide.
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doi:10.1016/j.ydbio.2007.06.001a Ras-GTPase-activating protein (GAP)-related domain that
binds active Rho family GTPases. IQGAP1 has been considered
to play pivotal roles in various cellular events such as cell
adhesion, migration, and polarization through binding diverse
proteins at these domains. It is localized to cell-to-cell contact
sites and it has been proposed to regulate cadherin-based cell
adhesion in mammalian cultured cells downstream of Rac1 and
Cdc42 (Fukata et al., 1999a,b; Kuroda et al., 1998). The cell-to-
cell adhesion molecule cadherin binds β-catenin which forms a
complex with α-catenin, and α-catenin is considered to bind
actin filaments. All of these proteins are necessary for proper
adhesion between mammalian cultured cells (Tsukita et al.,
1992). It has been shown in vitro that IQGAP1 and α-catenin
compete for binding to β-catenin (Kuroda et al., 1998). Over-
expression of IQGAP1 in these cells has been reported to
weaken cell-to-cell adhesion probably by dissociation of α-
catenin from the cadherin–catenin complex induced by the
interaction of IQGAP1 with β-catenin (Kuroda et al., 1998).
Thus, IQGAP1 is suggested to behave as a negative regulator in
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it has recently been shown that the loss of function of IQGAP1
by RNAi reduces actin filaments, E-cadherin and β-catenin at
cell-to-cell contact sites in MDCKII cells, suggesting that
IQGAP1 is a positive regulator for establishment of cell-to-cell
adhesion (Noritake et al., 2004). In this case, IQGAP1 is
suggested to cross-link actin filaments at cell-to-cell contact
sites. Therefore, the role of IQGAP1 in cell adhesion is still
enigmatic. IQGAP1 has also been reported to modulate actin
cytoskeleton and microtubules in migrating cells. In cultured
mammalian cells, IQGAP1 is co-localized with actin filaments
in ruffling membranes (Bashour et al., 1997; Kuroda et al.,
1996). Suppression of IQGAP1 expression by RNAi inhibits cell
migration and formation of cortical actin meshwork (Mataraza et
al., 2003; Watanabe et al., 2004). Furthermore, it has prevented
reorientation of microtubules in fibroblasts during wound
healing (Watanabe et al., 2004). IQGAP1 has also been shown
to interact with the microtubule-binding protein CLIP-170 and
adenomatous polyposis coli protein which accumulate at the
plus end of growing microtubules, suggesting that IQGAP1
captures and stabilizes that end of microtubules through binding
these molecules at the leading edge (Fukata et al., 2002;
Watanabe et al., 2004). Although IQGAP1 may participate in
both cell adhesion and migration, IQGAP1-knockout mice do
not demonstrate any developmental defects, which may be
explained by a functional redundancy with IQGAP2 (Li et al.,
2000).
IQGAP2 has originally been reported to be a liver-specific
protein, while recent studies have suggested that it is expressed
in other tissues too, albeit at a low level (Brill et al., 1996;
Schmidt et al., 2003; Zhou et al., 2003). Subcellular localiza-
tions of IQGAP1 and IQGAP2 are different from each other in
rabbit gastric parietal cells: IQGAP1 is localized to the baso-
lateral membrane whereas IQGAP2 is accumulated in the apical
membrane, suggesting that these IQGAPs have distinct
functions in these cells (Zhou et al., 2003). However, the role
of IQGAP2 is almost unknown.
In Xenopus laevis, two IQGAPs, XIQGAP1 and XIQGAP2,
which show high homology with human IQGAP1 and IQGAP2,
respectively, have been identified (Yamashiro et al., 2003). Both
XIQGAPs contain all the domains found in mammalian
IQGAPs. These XIQGAPs are localized to the cell-to-cell
contact sites in either cultured cells or embryos, but in a different
manner. XIQGAP1 is clearly concentrated in these sites,
especially the area where actin cables attach in cultured cells,
and in regions undergoing active morphogenetic movements in
embryos. On the other hand, XIQGAP2 is dimly localized to the
cell-to-cell contact sites both in cultured and embryonic cells. It
is additionally seen in the nuclei in these cells.
Here we suppressed expression of the XIQGAPs in embryos
using morpholino antisense oligonucleotides in order to clarify
function of these proteins during early development. It was re-
markable that the suppression of XIQGAP2 expression caused
loss of actin filaments, β-catenin and XIQGAP1 at cell-to-cell
contact sites and defect of cell adhesion in ectodermal and
mesodermal layers. These results suggest that XIQGAP2 is
crucial for cell adhesion during early development in X. laevis.Materials and methods
Eggs and embryos
Xenopus eggs were obtained from females injected with human chorionic
gonadotropin (Denka Seiyaku, Tokyo, Japan). They were in vitro fertilized by
using macerated tesitis, dejellied in 2% cysteine solution (pH 7.8), and cultured
in a modified Steinberg's solution (10 mM HEPES, pH 7.4, 60 mM NaCl,
0.67 mM KCl, 0.34 mM Ca (NO3)2, 0.83 mM MgSO4) until stage 8 and then
transferred to 0.1× modified Steinberg's solution.
Antibodies
Polyclonal antibodies against GST-XIQGAP2N were raised in guinea pigs.
To generate the fragment XIQGAP2N which corresponds to amino acid residues
37 to 343 of XIQGAP2, the XIQGAP2 cDNA in pBluescript SK− was amplified
by PCR using a 5′-primer (5′-TGCGGTCGACTCGCCTATGAATACCTGTG-
CCAT-3′) with a Sal I linker and a 3′-primer (5′-GATGCGGCCGCGGTAC-
CATGGTGAATT-3′) with a Not I linker. The PCR-amplified fragment was
subcloned into Sal I- andNot I-treated pGEX 4T-1 (Pharmacia Biotech, Uppsala,
Sweden). GST-fused XIQGAP2N was produced in XLI-Blue containing pGEX-
XIQGAP2N and purified with glutathione–Sepharose 4B beads (Pharmacia
Biotech). The antibodies were affinity-purified using GST-XIQGAP2N immo-
bilized on Affi-Gel 10 beads (Bio-Rad Labs., Hercules, CA), and then absorbed
with GST-XIQGAP1N (amino acid residues 38 to 449 of XIQGAP1) which was
prepared as described previously (Yamashiro et al., 2003).
Anti-XIQGAP1 polyclonal antibodies were previously prepared (Yamashiro
et al., 2003). Anti-actin monoclonal antibody (AC-40), anti-α-tubulin mono-
clonal antibody (DM1A) and anti-pan-cadherin polyclonal antibodies (C3678)
were purchased from Sigma-Aldrich. Anti-β-catenin polyclonal antibodies were
kindly provided by Dr. P. Hausen of the Max-Plank-Institut fur Entwicklungs-
biologie, Germany.
Microinjection of morpholino antisense oligonucleotides
Morpholino antisense oligonucleotides for XIQGAP1 (XIQGAP1-AS) and
XIQGAP2 (XIQGAP2-AS) were designed against the 5′-untranslated regions of
XIQGAP1 and XIQGAP2, respectively, immediately adjacent to the initiation
sites. Both the XIQGAP1-AS and the XIQGAP2-AS were 25-mer oligonucleo-
tides having the sequences 5′-CATCGACTTCCTCCGAAACGGACAT-3′ and
5′-ACGTCCTCATGGTTCATCCTGTTGC-3′, respectively (Gene Tools, LLC,
Corvallis, OR). A control oligonucleotide having a random sequence was also
produced (Gene Tools, LLC). Each oligonucleotide was dissolved in the
injection buffer (5 mM HEPES, pH 7.5, 88 mM NaCl, 1 mM KCl, 2 mM
MgCl2). Each blastomere of a two-cell stage embryo was injected with 20 ng of
the oligonucleotide. For simultaneous injection of the two different oligonucleo-
tides, each blastomere of a two-cell stage embryo was injected with a mixture of
XIQGAP1-AS (16 ng) and XIQGAP2-AS (8 ng), a mixture of XIQGAP1-AS
(16 ng) and control oligonucleotide (8 ng), a mixture of XIQGAP2-AS (8 ng)
and control oligonucleotide (16 ng), or control oligonucleotide alone (24 ng).
The embryo was then cultured in 0.1× modified Steinberg's solution until early
neurula. And then, the embryo was devitellinated and cultured in buffer A
(7.5 mMHEPES, pH 7.4, 88 mMNaCl, 1 mMKCl, 2.4 mMNaHCO3, 0.74 mM
CaCl2, 0.82 mM MgCl2).
To examine the efficiency of the depletion of XIQGAP1 or XIQGAP2 in
embryos by the injection of the morpholino antisense oligonucleotide, injected
embryos at an appropriate stage were processed for immunoblot analysis as
described below.
For immunostaining of embryos, Oregon Green 488-conjugated dextran
(MW 10,000, anionic, lysine fixable, Molecular Probes) (0.38 μg) was co-
injected with XIQGAP2-AS (8 ng) into one blastomere of a two-cell stage
embryo. The embryos were examined by fluorescence microscopy as described
below.
The full-length cDNA of XIQGAP2 was constructed by ligating the two
partial cDNA of XIQGAP2 (Yamashiro et al., 2003), and T7 promoter site was
added by PCR using a primer set of 5′-TAATACGACTCACTACTATAGG-
GAGCCCACCATGAACCATGAGGACGTCTCC-3′, and 5′-GCTGAGAGG-
Fig. 1. Effects of injection of morpholino antisense oligonucleotides into two-
cell stage embryos on the expression of XIQGAPs. (A) Reduction of XIQGAP1
at the late gastrula stage (stage 11) caused by injection of XIQGAP1-AS into the
two-cell stage embryo as shown by immunoblotting with anti-XIQGAP1
antibodies. (B) Reduction of XIQGAP2 at the mid-gastrula stage (stage 10) and
the early neurula stage (stage 13) caused by injection of XIQGAP2-AS into the
two-cell stage embryo as shown by immunoblotting with anti-XIQGAP2
antibodies. α-Tubulin was used as a loading control.
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mMESSAGE mMACHINE T7 kit (Ambion, Austin, TX) and 1–4 ng of it was
injected into each blastomere of two-cell stage embryos with or without
XIQGAP2-AS.
Histology
Embryos of different stages were fixed in MEMFA (0.1 M Mops, pH 7.4,
2 mM EGTA, 1 mM MgSO4, 0.1 M sucrose, 3.7% formaldehyde) for 1–4 h at
room temperature. The fixed embryos were dehydrated sequentially with an
ethanol series, cleared with toluene and embedded in paraffin (Paraplast Plus,
McCormick Scientific, St. Louis, MO). 10-μm-thick sections were cut on a
microtome, and paraffin was removed with xylene. The specimens were
rehydrated sequentially with an ethanol series and stained with hematoxylin and
eosin.
Preparation of extracts from embryos, SDS–PAGE and
immunoblotting
Extracts from embryos were prepared by homogenizing them on ice in two
volumes of the extraction buffer (10 mM Mops, pH 7.4, 0.1 M KCl, 5 mM
EGTA, 2 mM MgCl2, 0.1% Nonidet P-40) containing 10 μg/ml leupeptin,
10 μg/ml pepstatin, 10 μg/ml aprotinin and 1 mM phenylmethylsulfonyl-
fluoride. Homogenates were centrifuged at 10,000×g for 10 min to remove yolk
granules and lipids.
SDS–PAGE was carried out according to Laemmli (1970). Proteins were
electrophoretically transferred to polyvinylidene difluoride membrane (Immo-
bilon P; Millipore, Bedford, MA). The membrane was blocked with 5% skim
milk in PBS and then incubated with first and then second antibodies for 1–2 h,
respectively. The second antibodies used were horseradish peroxidase-
conjugated anti-rabbit IgG, anti-mouse IgG or anti-guinea pig IgG antibodies
(Amersham Pharmacia Biotech, Buckinghamshire, UK). Immunoreaction was
detected with an ECL system (Amersham Pharmacia Biotech). Bands were
scanned with a UMAX PowerLook III scanner at 300 dots/in. Band intensities
were quantified with Scion Image Beta 4.02 (Scion Corporation, Frederick,
MD).
Immunofluorescent staining of embryos and fluorescence microscopy
To prepare cryosections of embryos, embryos of different stages were fixed
in MEMFA for 1–4 h at room temperature, and then transferred to 70% (v/v)
methanol overnight at −20 °C. After several washes in PBS (125 mM NaCl,
1.65 mM NaH2PO4, 3.35 mM Na2HPO4, pH 7.4), the embryos were incubated
in PBS containing 20% (v/v) sucrose overnight at 4 °C. For rhodamine–
phalloidin staining, embryos were processed as above without the 70%
methanol treatment. The embryos were frozen in liquid nitrogen and 10 μm
frozen sections were cut with a Leitz cryostat. The sections were incubated with
anti-XIQGAP1 or anti-β-catenin antibodies for 1 h at room temperature, and
then incubated with rhodamine-conjugated goat anti-rabbit antibodies (Mole-
cular Probes) for 1 h at room temperature. F-actin staining was carried out with
1 U/ml rhodamine–phalloidin (Molecular Probes). The fluorescently stained
sections were examined by confocal microscopy using an LSM510 (Carl Zeiss).
Dissociation of cells from embryos and reaggregation
Control oligonucleotide (13 ng) or XIQGAP2-AS (13 ng) was co-injected
with fluorescein-conjugated dextran (MW 7000, anionic, lysine fixable;
Molecular Probes) or rhodamine-conjugated dextran (MW 7000, anionic, lysine
fixable; Molecular Probes) into each blastomere of the two-cell stage embryos.
The embryos were cultured overnight at 15 °C and then at 20 °C until the
gastrula stage (10.5). Dorsal half areas of the animal cap and the marginal zone
from ten embryos were excised and incubated for 30 min in 0.5× PBS and
ectodermal and mesodermal cells were dissociated by gentle pipetting. The
dissociated cells were collected by centrifuging at 120×g for 3 min, and
resuspended in the modified Steinberg's solution containing 0.1% BSA. The cell
suspension was layered on 1.5% agarose, gyrated to concentrate the cells, and
kept for 12 h at room temperature to let the cells reaggregate.Results
Injection of XIQGAP2-AS causes dorsal lesions in neurula
embryos
Expression of XIQGAP1 or XIQGAP2 was suppressed
using morpholino antisense oligonucleotides in order to inves-
tigate the function of the XIQGAPs during early development.
When two-cell stage embryos were injected with XIQGAP1-
AS, the expression of XIQGAP1 at the late gastrula stage was
efficiently reduced as compared to that in uninjected embryos
(Fig. 1A). The band intensity of XIQGAP1 in the extract of
XIQGAP1-AS-injected embryos at the late gastrula stage de-
creased to 36.4±5.3% of that in the extract of uninjected
embryos (mean±S.D., n=3). However, the embryos appeared
to develop normally at least until the tailbud stage (data not
shown).
Next, embryos were injected with XIQGAP2-AS. The ex-
pression of XIQGAP2 was reduced at the mid-gastrula stage
and the early neurula stage as compared to that in uninjected
embryos (Fig. 1B). The band intensity of XIQGAP2 in the
extract of XIQGAP2-AS-injected embryos at the early neurula
stage was 40.7±10.9% of that in the extract of uninjected
embryos (mean±S.D., n=3). The embryos developed normally
until the early neurula stage. However, at the mid-neurula stage,
the dorsal region of the embryos developed lesions, and the
embryos were disintegrated afterwards. In order to observe the
effect of the XIQGAP2-AS injection more clearly, one blas-
tomere of the two-cell stage embryos was injected with 20 ng of
XIQGAP2-AS or control oligonucleotide, and then they were
cultured in the presence of calcium ions at a physiological
concentration to maintain Ca2+-dependent cell-to-cell adhesion.
Embryos injected with the control oligonucleotide developed
normally under this condition until the tailbud stage (Figs. 2A, c
and d). The XIQGAP2-AS-injected embryos seemed to develop
normally until the early neurula stage (Fig. 2A, a). However,
lesions were observed in the dorsal region in one side of the
embryo at the mid-neurula stage. This half of the embryo was
derived from the XIQGAP2-AS-injected blastomere. The les-
Fig. 2. Injection of XIQGAP2-AS into two-cell stage embryos lead to lesions. XIQGAP2-AS (20 ng) or control oligonucleotide (20 ng) was injected into one blastomere
of the two-cell stage embryos. The injected embryoswere cultured in buffer A (seeMaterials andmethods) after the neurula stage tomaintain Ca2+-dependent cell-to-cell
adhesion. (A) An XIQGAP2-AS-injected embryo developed normally until early neurula (a, stage 13), but lesions were observed during the neurula stage. Finally, the
ectodermal layer and the mesodermal layer of the half of the embryo were disintegrated at the early tailbud stage (b, stage 24, arrow). (c, d) Control oligonucleotide-
injected embryos developed normally. Dorsal views are shown. The embryos are placed such that their anterior faces top (a, c) or left (b, d). (B) Transverse sections of
embryos at the neurula stage (stage 20) and the early tailbud stage (stage 24). (a) An embryo at the neurula stage previously injected with XIQGAP2-AS. The arrow
indicates cells detached from the ectoderm. (b) An embryo at the early tailbud stage previously injected with XIQGAP2-AS. The ectodermal layer and the mesodermal
layer of the right side of the embryo (arrow) were disintegrated. (c) An embryo at the neurula stage previously injectedwith control oligonucleotide. (d) An embryo at the
early tailbud stage injected with control oligonucleotide. ec, ectoderm; me, mesoderm; en, endoderm; no, notochord; nt, neural tube.
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(Fig. 2A, b). Since the endoderm was exposed in the half of the
embryos, the ectodermal layer and the mesodermal layer might
have been broken. All XIQGAP2-AS-injected embryos which
survived beyond the late gastrula stage showed this phenotype
at the neurula stage (Table 1).
Transverse sections of the XIQGAP2-AS-injected embryos
at the neurula stage showed that the structures of the notochord
and the neural fold seemed to be almost normal. However,
round cells which had detached from the ectoderm of the neural
fold were observed (Fig. 2B, a). Sections of the embryos at theearly tailbud stage showed disintegration of both the ectodermal
and the mesodermal layers on one side of the embryo (Fig. 2B,
b). These lesions were not observed in embryos injected with
control oligonucleotide (Figs. 2B, c and d). Two possibilities
may account for the phenotype of the embryos injected with
XIQGAP2-AS. First, suppression of XIQGAP2 expression may
have caused loss of cell adhesion in the ectoderm and the me-
soderm. Second, cells in the XIQGAP2-AS-injected embryos
may have undergone apoptosis and therefore lost an ability to
adhere the neighboring cells. To test the second possibility,
sections of the embryo were stained with DAPI to examine
Table 1
Summary of injection of XIQGAP2-AS
Total no. of
embryos
No. of neurula stage
embryos
Others
Normal Ectodermal
lesion
Injected oligonucleotide
XIQGAP2-AS 45 0 32 13
Control oligonucleotide 39 25 0 14
Noninjected 116 88 0 28
Forty ng of the oligonucleotide was injected into two blastomeres (20 ng each)
of 2-cell stage embryos. “Others” include embryos which died before the late
gastrula stage. Three independent series of experiments were performed for
these injections. The numbers are sums of these results.
Table 2
Effect of simultaneous reduction of both XIQGAPs
Injected
oligonucleotides
Total
number
of
embryos
Number of embryos
which showed
ectodermal lesions
Normal Others
Gastrula to
early neurula
Neurula
XIQGAP1-AS (32 ng)+
XIQGAP2-AS (16 ng)
8 7 0 0 1
XIQGAP2-AS (16 ng)+
Control oligo (32 ng)
9 0 9 0 0
XIQGAP1-AS (32 ng)+
Control oligo (16 ng)
8 0 0 6 2
Control oligo (48 ng) 9 0 0 9 0
Mixture of oligonucleotides or control oligonucleotide (total amount of 48 ng)
was injected into two blastomeres (24 ng each) of 2-cell stage embryos. “Others”
include embryos which died before the late gastrula stage. Two independent
series of experiments were performed for these injections. The numbers are
sums of these results.
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in these cells appeared to be normal, and neither condensation
nor segregation which are the features of apoptotic cells was
observed in these cells (data not shown). Thus, the detachment
of the cells in the XIQGAP2-AS-injected embryos was likely to
be due to loss of cell adhesion in ectoderm and mesoderm.
The defects in XIQGAP2-AS-injected embryos were not
rescued by co-injection of XIQGAP2 mRNA encoding the
entire coding region of XIQGAP2 cDNA probably because the
XIQGAP2-AS suppressed both the injected and endogenous
mRNAs. Interestingly, however, the injection of XIQGAP2
mRNA alone generated partially exogastrulated embryos (Sup-
plemental Fig. 1). This phenotype was suppressed by the simul-
taneous injection of XIQGAP2-AS, suggesting that the inject-
ion of XIQGAP2-AS specifically suppressed the expression of
XIQGAP2.
Simultaneous reduction of both XIQGAPs hastens the
appearance of the dorsal lesions
To investigate effect of simultaneous reduction of both
XIQGAPs during early development, a mixture of XIQGAP1-
AS and XIQGAP2-AS was injected into both blastomeres of
two-cell stage embryos. A mixture of XIQGAP1-AS and con-
trol oligonucleotide, a mixture of XIQGAP2-AS and control
oligonucleotide, or control oligonucleotide alone was also in-
jected into embryos in the same way (Table 2). The injection
of the mixture of XIQGAP2-AS and control oligonucleotide
caused the dorsal lesions at the neurula stage as in the case of the
injection of XIQGAP2-AS alone. Embryos injected with the
mixture of XIQGAP1-AS and control oligonucleotide, or
control oligonucleotide alone developed normally as described
above. However, the injection of the mixture of XIQGAP1-AS
and XIQGAP2-AS caused the lesions at the late gastrula stage
or the early neurula stage, several hours earlier than those seen
in embryos injected with the mixture of XIQGAP2-AS and
control oligonucleotide. Therefore, it is likely that both XIQ-
GAP1 and XIQGAP2 are involved in cell adhesion during early
Xenopus development. Since the phenotype of the embryos
injected with the mixture of XIQGAP1-AS and XIQGAP2-AS
was similar to that caused by XIQGAP2-AS alone, we further
analyzed the effects of the injection of XIQGAP2-AS.Injection of XIQGAP2-AS does not alter the expression of
adherens junction proteins
First, the injection of XIQGAP2-AS caused reduction of
XIQGAP2 as shown in Fig. 1B, while expression level of
α-tubulin as a control protein did not change (Fig. 3). We
examined by immunoblotting using extracts from embryos
injected with XIQGAP2-AS or noninjected embryos whether
the injection affected expression levels at the early neurula stage
of actin, cadherin and β-catenin, all of which are adherens
junction proteins, and that of XIQGAP1 which is localized to
cell-to-cell contact sites in Xenopus embryos. Under these
conditions, the expression levels of actin, cadherin, β-catenin
and XIQGAP1 were not altered. The anti-cadherin antibodies
recognized only one protein of 140 kDa which was thought to be
E-cadherin by its molecular weight, although E-cadherin, N-
cadherin and U-cadherin have been reported to be expressed in
neurula (Detrick et al., 1990; Schneider et al., 1993).
Injection of XIQGAP2-AS causes reduction of accumulation of
actin filaments, β-catenin and XIQGAP1 at cell-to-cell contact
sites
The effect of the injection of XIQGAP2-AS on localization
of actin filaments, β-catenin and XIQGAP1 was examined.
XIQGAP2-AS or control oligonucleotide was injected into one
blastomere of two-cell stage embryos together with a fixable
dextran conjugated with Oregon Green which served as a line-
age tracer. The embryos were fixed at the neurula stage,
sectioned transversely and stained with rhodamine–phalloidin,
anti-β-catenin antibodies or anti-XIQGAP1 antibodies.
The fluorescence of Oregon Green dextran was observed in
the half of the embryo, indicating that this half was derived from
the blastomere injected with the antisense oligonucleotide. F-
actin was concentrated in cell cortex and borders of the cells in
the ectodermal layer of the noninjected half. On the other hand,
the intensity of F-actin staining in the corresponding regions in
the XIQGAP2-AS-injected half was significantly low (Figs. 4A,
Fig. 3. Immunoblot analysis of XIQGAPs and adherens junction proteins in
extracts from stage 20 embryos. The two blastomeres of the two-cell stage
embryos were injected with XIQGAP2-AS (20 ng each) or control
oligonucleotide (20 ng each). The blots were probed with antibodies against
the proteins indicated in the figure. The injection of XIQGAP2-AS efficiently
caused reduction of XIQGAP2 (top panel), while expression levels of the other
proteins were not altered (lower panels). α-Tubulin was used as a loading
control.
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nucleotide-injected half was not altered. Similarly, β-catenin
was localized to the ectodermal cell borders in the noninjected
half, but was hardly detected in the corresponding region in the
XIQGAP2-AS-injected half (Figs. 4A, c, d, c′, and c′′). XIQ-
GAP1 was highly concentrated in the ectodermal cell borders.
But its amount was markedly reduced in these regions in the
XIQGAP2-AS-injected half (Figs. 4A, e, f, e′, and e′′). No
difference in either F-actin or XIQGAP1 distribution was ob-
served between control oligonucleotide-injected and nonin-
jected halves (Fig. 4B). These results indicate that the injection
of XIQGAP2-AS into the embryos caused the reduction of
accumulation of actin filaments, β-catenin and XIQGAP1 at the
sites of cell-to-cell contact in the ectodermal layer.
Injection of XIQGAP2-AS reduces the adhesive properties of
embryonic cells
In order to test whether the suppression of XIQGAP2 ex-
pression affected cell-to-cell adhesion, a blastomere reaggrega-
tion assay was performed using cells dissociated from the
animal cap. The cells derived from control oligonucleotide-
injected embryos reaggregated into large clumps (Fig. 5a).
However, the cells derived from the XIQGAP2-AS-injected
embryos did not reaggregate (Fig. 5b). Next, we obtained
dissociated cells from embryos co-injected with the above
oligonucleotide and either fluorescein–dextran (Fdx) or rhoda-mine–dextran (Rdx). When the cells containing control oligonu-
cleotide and Fdx and those containing control oligonucleotide and
Rdx were mixed, large clumps consisting of the two kinds of the
cells were formed (Figs. 5c–e). However, when the cells
containing XIQGAP2-AS and Fdx and those containing control
oligonucleotide and Rdx were mixed, only small clumps were
observed (Figs. 5f–h). Most cells in these clumps showed
rhodamine fluorescence, while those showed fluorescein fluores-
cence did not aggregate (Figs. 5f–h). These results strongly
suggest that the injection of XIQGAP2-AS caused a significant
reduction in adhesive ability in ectodermal and mesodermal cells.
Discussion
Suppression of XIQGAP2 expression by injection of a mor-
pholino antisense oligonucleotide induced ectodermal lesions in
neurula embryos. It reduced the amounts of actin filaments and
β-catenin in embryos, both of which are adherens junction
components, and XIQGAP1 at the cell-to-cell contact sites
especially in the ectodermal layer, but did not alter the express-
ion levels of these proteins. It was confirmed that cell-to-cell
adhesion was significantly reduced in embryonic cells by the
observation of detached cells in the ectoderm and by a blasto-
mere reaggregation assay. These results suggest that XIQGAP2
is crucial for cell-to-cell adhesion in ectodermal cells probably
as a scaffold protein in the junctional complex. This notion is
supported by the fact that XIQGAP2 is localized to cell-to-cell
contact sites both in cultured Xenopus cells and in Xenopus
embryos (Yamashiro et al., 2003).
The XIQGAP2-AS injection seemed to reduce the adhesion
in the mesodermal layer as well. Since this layer was also dis-
integrated in the tailbud embryos. Also in the blastomere-
reaggregation assay of animal cap cells which contained both
ectodermal and mesodermal cells, all the cells reaggregated
when control oligonucleotide had been injected while all the
cells did not reaggregate when XIQGAP2-AS had been injected.
However, the stainings for F-actin, β-catenin, and XIQGAP1 in
the mesoderm were not strong as compared with the ectoderm. It
may be that the adhesion in the ectodermal layer is primarily
important to maintain the integrity of the developing embryo.
Similar observation and idea have been described previously for
α- and β-catenin in Xenopus embryos (Schneider et al., 1993).
On the other hand, since XIQGAP2 may modulate actin
cytoskeleton as a putative actin-cross-linking protein (Brill et al.,
1996), it is also possible that impaired actin-based morphogenetic
cell movements during neurulation caused the dorsal lesions. We
do not know at present whether the impairment of cell migration
occurred in the XIQGAP2-AS-injected embryos and whether it
was an additional factor for the loss of cell adhesion.
XIQGAP1 has also been localized to cell-to-cell contact sites
both in cultured cells and in developing embryos (Yamashiro et
al., 2003). In mammalian cells, IQGAP1, the counterpart of
XIQGAP1, has been implicated in the cadherin-mediated cell-
to-cell adhesion (Fukata et al., 1999a; Kuroda et al., 1998). In
the present study, the injection of an XIQGAP1 morpholino
antisense oligonucleotide did not show any effect on early Xe-
nopus development. However, the simultaneous injection of
Fig. 4. Loss of actin filaments, β-catenin and XIQGAP1 at the ectodermal cell borders in XIQGAP2-AS-injected embryos. XIQGAP2-AS (13 ng) was injected into
one blastomere of two-cell stage embryo together with a fixable dextran conjugated with Oregon Green, which was used as a lineage tracer. (A) Embryos at the neurula
stage (stage 18) were fixed, sectioned transversely, and then stained with rhodamine–phalloidin (a), anti-β-catenin antibodies (c) or anti-XIQGAP1 antibodies (e). a′
and a′′, enlarged images of boxed regions in a. c′ and c′′, enlarged images of boxed regions in c. e′ and e′′, enlarged images of boxed regions in e. b, d and f, merged
images of Oregon Green–dextran (green) and Rhodamine–phalloidin (b), anti-β-catenin (d) or anti-XIQGAP1 (f). (B) Control oligonucleotide (13 ng) was injected as
in panel A. Embryos at the neurula stage (stage 20) were fixed, sectioned and stained with rhodamine–phalloidin (a) or anti-XIQGAP1 antibodies (c). b and d, merged
images of Oregon Green–dextran and rhodamine–phalloidin (b) or anti-XIQGAP1 antibodies (d). ec, ectoderm; no, notochord; so, somites; nu, neural plate and neural
tube. Bars=100 μm.
491S. Yamashiro et al. / Developmental Biology 308 (2007) 485–493
Fig. 5. Injection of XIQGAP2-AS inhibits Ca2+-dependent cell reaggregation. Control oligonucleotide (13 ng) or XIQGAP2-AS (13 ng) was injected into each
blastomere of two-cell stage embryos together with fluorescein–dextran (Fdx) or rhodamine–dextran (Rdx) which was used as a lineage tracer. Animal cap cells
dissociated from control oligonucleotide-injected embryos reaggregated in the Steinberg's solution which contained Ca2+ (a), while those of XIQGAP2-AS-injected
embryos did not reaggregate (b). (c–e) Mixture of two groups of animal cap cells dissociated from control oligonucleotide-injected embryos one contained Fdx and the
other contained Rdx formed large clumps in the Steinberg's solution. (f–h) When animal cap cells dissociated from XIQGAP2-AS and Fdx-co-injected embryos and
those from control oligonucleotide and Rdx-co-injected embryos were mixed, the cells containing control oligonucleotide and Rdx-formed clumps, while those
containing XIQGAP2-AS and Fdx did not reaggregate. Bar=100 μm.
492 S. Yamashiro et al. / Developmental Biology 308 (2007) 485–493antisense oligonucleotides against XIQGAP1 and XIQGAP2
hastened the appearance of the dorsal lesion in the injected
embryo, suggesting that XIQGAP1 also participates in the
maintenance of cell adhesion in the embryo. The inefficiency of
the injection of the XIQGAP1 morpholino antisense oligonu-
cleotide alone is probably due to insufficient suppression of the
expression of the protein.
Rho-family small GTPases, Rac and Cdc42 are also impli-
cated in the regulation of cell-to-cell adhesion in Xenopus em-
bryos. Ectopic expression of the dominant negative human Rac
(N17rac) has been reported to cause dissociation of cells in the
inner layers of the blastocoel roof (Hens et al., 2002). Over-
expression of the wild type Xenopus Cdc42 decreases the Ca2+-
dependent cell adhesion in Xenopus embryonic cells (Choi and
Han, 2002). Both XIQGAP1 and XIQGAP2 contain a Ras-
GAP-related domain similar to that present in mammalian
IQGAP1, which has been shown to interact with active Cdc42
and Rac1. Therefore, the XIQGAPs probably lie downstream of
Xenopus Rac and/or Cdc42 in the regulation of Ca2+-dependent
cell adhesion.
Recently, the model of cell-to-cell adhesion, in which cad-
herins are linked to the actin cytoskeleton through α-catenin and
β-catenin, has been denied, since α-catenin does not simulta-
neously interact with actin filaments and the E-cadherin–β-
catenin complex (Drees et al., 2005; Yamada et al., 2005).
Though several reports have claimed that α-catenin is necessary
for cell-to-cell adhesion, this notion is still needed to be clar-ified. Nevertheless, IQGAPs are strong candidates for scaffold
proteins that tether actin filaments to the E-cadherin–β-catenin
complex at adherens junction.
It is not yet clear how XIQGAP2 localizes actin filaments, β-
catenin and XIQGAP1 at cell-to-cell contact sites. Although
mammalian IQGAP2 has been shown to bind actin filaments,
calmodulin, Rac and Cdc42, it is not known whether it binds
other proteins that compose the junctional complex. It has
recently been reported that mammalian IQGAP1 self-associates
both in vitro and in vivo via their IQ motifs (Ren et al., 2005).
Thus, it is tempting to speculate that XIQGAP2 binds XIQ-
GAP1 via the IQ motifs and this may be necessary for local-
ization of XIQGAP1 at cell-to-cell contact sites. To understand
the function of XIQGAP2 in cell adhesion, identification of
XIQGAP2-binding proteins is necessary.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.ydbio.2007.06.001.
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